Based in the United States, GlycosBio is a startup.
GlycosBio develops engineered lipid-based technologies to enhance the therapeutic performance and bioavailability of natural bioactive molecules, focusing on microbiota research and advanced lipid engineering for medical and nutritional applications.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.